Analysed MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) News Sources
Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH
27-05-2026
yahoo.com
Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More
30-05-2026
fool.com
Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Weakness
02-06-2026
yahoo.com
Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026
03-06-2026
yahoo.com
Madrigal (MDGL) Data Highlights Rezdiffra’s Cardiometabolic Benefits for MASH Patients at EASL Congress
04-06-2026
yahoo.com
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
04-06-2026
yahoo.com
The Bull Case For Madrigal Pharmaceuticals (MDGL) Could Change Following New Rezdiffra Cardiometabolic Data Release
09-06-2026
yahoo.com
What is the current price of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)?
The current price of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) is $501.19.
MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) absolute price change since previous trading day?
The absolute price change of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) since the previous trading day is $1.43.
MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) percentage price change since previous trading day?
The percentage price change of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) since the previous trading day is 0.2861%.
What is the most recent average sentiment score for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)?
The most recent average sentiment score for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)?
The most recent sentiment for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) is .
SEC-8K** Filing Available For MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.